Lumos Pharma | NLNK - 負債



負債 変化する 日付
Agenus USD 35.54M 2.34M 2025-03
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Capricor Therapeutics USD 3.38M 0 2025-03
Celldex Therapeutics USD 2.62M 410K 2025-09
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Eli Lilly USD 42.51B 2.6B 2025-09
Grifols EUR 9.23B 626.05M 2024-12
Incyte USD 40.41M 855K 2025-12
Intrexon USD 0 13.82M 2024-06
Merck USD 41.37B 5.97B 2025-09
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 60.85B 78M 2025-09
Prothena USD 9.08M 699K 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09